Clinical trials generate vast amounts of valuable data, including bio-samples, imaging results, and reports of adverse events. Efficiently reusing these assets can accelerate research while reducing risks and costs. However, challenges such as data fragmentation and limited access often complicate these efforts.
In this webinar, experts from AstraZeneca and Boehringer Ingelheim will discuss how they utilize the DISQOVER platform to build cohorts, enhancing the accessibility and usability of clinical trial data. Learn how DISQOVER’s intuitive knowledge discovery platform allows researchers to quickly integrate, explore, and utilize clinical trial data—without requiring advanced data science expertise.
In this session, you’ll hear directly from:
- Ben Gardner – AstraZeneca, R&D Lead for Data Mesh and Semantic Infrastructure
- Karsten Quast -Boehringer Ingelheim, Data Domain Owner
They’ll share how DISQOVER empowers their teams to integrate, explore, and use clinical trial data—without needing advanced data science expertise.
Why should you join?
- See what’s new: Explore the latest DISQOVER features that simplify and speed up cohort creation
- Learn from experience: Hear real-world stories from AZ and BI on improving clinical data reuse
- Ask the experts: Participate in a live Q&A with Ben and Karsten to dive deeper into strategies, challenges, and best practices
Register here